Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The TRPV1 and TRPA1 channels are non-selective cation channels belonging to the Transient Receptor Potential (TRP) superfamily, primarily expressed in nociceptive sensory neurons [1.4.1]. TRPV1, known as the capsaicin receptor, is activated by noxious heat (>43°C), low pH, and vanilloids, while TRPA1, the wasabi receptor, responds to noxious cold (<17°C) and various electrophilic irritants [1.3.1, 1.4.5]. These channels are frequently co-expressed and functionally interlinked, playing a critical role in the integration of painful stimuli and the mediation of neurogenic inflammation through the release of neuropeptides like CGRP and substance P [1.4.1, 1.4.4]. In disease states, they contribute to chronic pain, respiratory conditions like asthma and cough, and inflammatory skin disorders [1.2.1, 1.4.3]. Therapeutic strategies involve the development of dual antagonists to provide enhanced analgesic and anti-inflammatory effects compared to single-target agents [1.1.1, 1.2.2]. However, clinical development has faced significant challenges, such as TRPV1-mediated hyperthermia and the risk of impaired thermal sensation, which can lead to scalding injuries [1.1.1, 1.3.1].
Antagonism of the ion channels to inhibit cation influx and subsequent neuronal depolarization, or desensitization through prolonged agonism [1.1.1, 1.4.3].
12 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transient receptor potential cation channel subfamily V member 1 (TRPV1) and Transient receptor potential cation channel subfamily A member 1 (TRPA1) (TRPV1/TRPA1).